• Oklo Inc. recently reported second-quarter 2026 results, with sales of US$1.21 million and a net loss of US$48.54 million, widening its per-share loss from continuing operations to US$0.28 compared with US$0.18 a year earlier.
• A day before releasing these results, Oklo achieved first criticality at its Groves low-power test reactor on private land under the U.S. Department of Energy’s Reactor Pilot Program, marking a key step toward building domestic isotope production capabilities for healthcare, industry, research, space, and national security.
• We’ll now examine how achieving first criticality at the Groves test reactor may influence Oklo’s investment narrative and future project execution.

The future of work is here. Discover the 38 top robotics and automation stocks leading the charge in AI-driven automation and industrial transformation.

Oklo Investment Narrative Recap

To own Oklo, you need to believe its integrated model across power, fuel, and isotopes can eventually convert today’s small revenue base and widening losses into durable cash flows. The Groves first criticality milestone directly supports that thesis by showing Oklo can take a reactor from greenfield to startup, but the bigger near term swing factor remains execution risk and capital needs across multiple large projects rather than this single test reactor outcome.

The Groves first criticality announcement is the most relevant development here, because it turns Oklo’s isotope ambitions into an operating asset that may inform future deployments. The project has produced hands on experience in engineering, construction, fuel procurement, and operations that could reduce execution uncertainty on Aurora powerhouses and fuel cycle sites, which are central to converting Oklo’s reported 14 gigawatt pipeline into contracted, revenue producing facilities over time.

Yet alongside these milestones, investors should also weigh the possibility that Oklo’s high cash needs and continued operating losses could eventually require more equity issuance that existing shareholders should be aware of...

Oklo’s narrative projects $76.2 million revenue and $11.3 million earnings by 2029. This implies an earnings increase of about $140 million from -$128.9 million today.

Uncover how Oklo's forecasts yield a $88.63 fair value, a 106% upside to its current price.

Exploring Other Perspectives

Before this news, the most optimistic analysts were assuming Oklo could reach about US$115.7 million of revenue and US$16.8 million of earnings by 2029, which is a far more upbeat path than the baseline view and leans heavily on its integrated power, fuel, and isotopes platform, so you should recognize how wide the range of opinions is and consider whether those expectations still feel reasonable in light of Groves reaching first criticality.

Explore 31 other fair value estimates on Oklo - why the stock might be worth over 2x more than the current price!

Reach Your Own Conclusion

Disagree with existing narratives? Extraordinary investment returns rarely come from following the herd, so go with your instincts.

• A great starting point for your Oklo research is our analysis highlighting 1 key reward and 6 important warning signs that could impact your investment decision.
• Our free Oklo research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate Oklo's overall financial health at a glance.

Seeking Other Investments?

Early movers are already taking notice. See the stocks they're targeting before they've flown the coop:

• Find 52 companies with promising cash flow potential yet trading below their fair value.
• The best AI stocks today may lie beyond giants like Nvidia and Microsoft. Find the next big opportunity with these 17 smaller AI-focused companies with strong growth potential through early-stage innovation in machine learning, automation, and data intelligence that could fund your retirement.
• We've uncovered the 12 dividend fortresses yielding 5%+ that don't just survive market storms, but thrive in them.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.